Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands
Every batch is independently tested by third-party laboratories
Each serving delivers 2500 mg of CLA and 2500 mg of L-Carnitine, helping to enhance fat oxidation and athletic performance
Vasodilator effect of glucagon: Receptorial crosstalk among glucagon, GLP-1, and receptor for glucagon and GLP-1
GLP-1 medications can help reduce cravings for foods with fewer nutrients
Accelerated gastric emptying: Following research showing that ipamorelin accelerated gastric emptying in adult male rats [4], ipamorelin was evaluated in one phase II clinical trial [5]